Worldwide Clinical Trials Revenue and Competitors
Estimated Revenue & Valuation
- Worldwide Clinical Trials's estimated annual revenue is currently $535.3M per year.
- Worldwide Clinical Trials's estimated revenue per employee is $137,635
Employee Data
- Worldwide Clinical Trials has 3889 Employees.
- Worldwide Clinical Trials grew their employee count by 15% last year.
Worldwide Clinical Trials's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder & CEO | Reveal Email/Phone |
2 | Executive Director, Strategic Accounts | Reveal Email/Phone |
3 | Executive Director Business Development | Reveal Email/Phone |
4 | Chief Staff, GCD | Reveal Email/Phone |
5 | Executive Director, Global Sales Development and Sales Enablement Technology Solutions | Reveal Email/Phone |
6 | Sr VP, Global Site Activation | Reveal Email/Phone |
7 | Executive Director Business Development | Reveal Email/Phone |
8 | Sr. VP Finance | Reveal Email/Phone |
9 | Chief Scientist | Reveal Email/Phone |
10 | VP, Global Commercial Operations | Reveal Email/Phone |
Worldwide Clinical Trials Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.8M | 29 | 4% | N/A | N/A |
#2 | $3.2M | 16 | 0% | N/A | N/A |
#3 | $83.2M | 414 | 7% | N/A | N/A |
#4 | $31M | 154 | 56% | N/A | N/A |
#5 | $66.6M | 265 | 0% | $35M | N/A |
#6 | $10.9M | 54 | 6% | N/A | N/A |
#7 | $6.8M | 34 | -6% | N/A | N/A |
#8 | $165.7M | 216 | 14% | $250.7M | N/A |
#9 | $26.5M | 132 | -11% | $637.8K | N/A |
#10 | $49.4M | 246 | 6% | N/A | N/A |
What Is Worldwide Clinical Trials?
Founded in 1986 by Dr. Neal R. Cutler and his team, Worldwide Clinical Trials, Inc., began as an investigational site before expanding to become a global CRO in 1995. Worldwide Clinical Trials’ business philosophy, which places an emphasis on site and patient centered clinical research, is a reflection of that pedigree. Known for developing several revolutionary and innovative techniques in interventional clinical research, both the investigative site, and later the CRO, became a champion of the need for methodological rigor in the design and execution of clinical trials, across therapeutic areas and phases, but particularly in central nervous system disorders in which accurate diagnostics and sensitive psychiatric ratings and neuropsychological assessments are mandatory. The exceptional emphasis upon follow-through and senior management oversight for all projects increased the quality, safety and the speed of the drug development and has become a hallmark of the WCTs brand.
keywords:N/A
N/A
Total Funding
3889
Number of Employees
$535.3M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Worldwide Clinical Trials News
Zanidatamab has the potential to meet the urgent global clinical need for a ... and pivotal clinical trials globally as a targeted treatment...
... the U.S. Food and Drug Administration to approve emergency use of ... but Pfizer is conducting worldwide clinical trials with more than...
The Global Clinical Trials Market size was estimated at USD 29,712.55 million in 2020, is expected to reach USD 32,276.86 million in 2021, and...
Worldwide's expertise is world renowned, and we have no doubt that they will be a crucial partner in bringing forth Psilera’s next generation mental health therapies to future patients TAMPA, Fla. (PRWEB) July 13, 2021 Psilera Inc., formerly Psilera Bioscience (“Psilera”), a Florida-based biot ...
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Mar 23, 2021-- Worldwide Clinical Trials, Inc. (Worldwide), the industry’s leading global, midsized, full-service contract research organization (CRO), announced today that Sherilyn Adcock, RPH, PHD, has been promoted to chief scientific officer, E ...
Other Companies in Morrisville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $916.2M | 4558 | 9% | N/A |
#2 | $12980M | 5376 | 5% | N/A |
#3 | $1775.2M | 8745 | N/A | N/A |
#4 | $8550.7M | 22621 | 4% | N/A |
#5 | $4980M | 28082 | 4% | N/A |